glp-1/gip/glucagon triple agonist name Retatrutide for weight loss: Study shows 30% body weight loss Frontiers | Mechanisms of action
Description
Data availability All data relevant to the findings are included in the manuscript
W., et al
Loeser RF, Goldring SR, Scanzello CR, Goldring MB
Toki S, Newcomb DC, Printz RL, Cahill KN, Boyd KL, Niswender KD, et al
Rehan ST, Siddiqui AH, Khan Z, Imran L, Syed AA, Tahir MJ, et al
Anti-inflammation and Anti-oxidation: the Key to unlocking the Cardiovascular potential of SGLT2 inhibitors and GLP1 receptor agonists
